{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T23:06:31Z","timestamp":1788303991202,"version":"build-2803163510"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,8,26]],"date-time":"2024-08-26T00:00:00Z","timestamp":1724630400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,8,26]],"date-time":"2024-08-26T00:00:00Z","timestamp":1724630400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100018778","name":"Al-Azhar University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100018778","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ir J Med Sci"],"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Vitiligo is an inflammatory, autoimmune disorder. Its pathogenesis is unclear. A neutrophil activation marker (calprotectin) is a protein complex present in many different types of cells and may be used as an indicator of inflammation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Aims<\/jats:title>\n                <jats:p>This study is to assess calprotectin levels in non-segmental vitiligo patients and compare them to the severity of the illness to identify potential associations.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The present inquiry was conducted on thirty non-segmental vitiligo patients and thirty healthy volunteers matched in terms of age and gender. The Vitiligo Area Scoring Index was used to assess the vitiligo severity. Calprotectin levels were measured in serum samples obtained from all participants by Enzyme Linked Immunosorbent Assay.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Compared to controls, non-segmental vitiligo patients had considerably elevated serum calprotectin levels. Additionally, calprotectin levels were shown to have a significant positive association with disease severity (<jats:italic>r<\/jats:italic>\u2009=\u20090.833, <jats:italic>P<\/jats:italic>\u2009=\u20090.000).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Elevated levels of serum calprotectin in non-segmental vitiligo patients relative to healthy individuals with high sensitivity indicated that it may have a role in the vitiligo pathophysiology and can act as a marker for disease monitoring.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s11845-024-03777-4","type":"journal-article","created":{"date-parts":[[2024,8,26]],"date-time":"2024-08-26T14:03:09Z","timestamp":1724680989000},"page":"2797-2802","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Evaluation of neutrophil activation marker in patients with vitiligo"],"prefix":"10.1007","volume":"193","author":[{"given":"Hala M.","family":"El-Sadek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asmaa A.","family":"Elmadbouly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basma E. M.","family":"Risha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,26]]},"reference":[{"key":"3777_CR1","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1159\/000506103","volume":"236","author":"C Bergqvist","year":"2020","unstructured":"Bergqvist C, Ezzedine K (2020) Vitiligo: a review. Dermatology 236:571\u2013592. https:\/\/doi.org\/10.1159\/000506103","journal-title":"Dermatology"},{"key":"3777_CR2","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1007\/s13671-014-0098-6","volume":"4","author":"NB Silverberg","year":"2015","unstructured":"Silverberg NB (2015) The Epidemiology of Vitiligo. Current dermatology reports 4:36\u201343. https:\/\/doi.org\/10.1007\/s13671-014-0098-6","journal-title":"Current dermatology reports"},{"key":"3777_CR3","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/1477-7525-1-58","volume":"1","author":"D Parsad","year":"2003","unstructured":"Parsad D, Dogra S, Kanwar AJ (2003) Quality of life in patients with vitiligo. Health Qual Life Outcomes 1:58. https:\/\/doi.org\/10.1186\/1477-7525-1-58","journal-title":"Health Qual Life Outcomes"},{"key":"3777_CR4","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.abd.2021.09.008","volume":"97","author":"HZ Marchioro","year":"2022","unstructured":"Marchioro HZ, Silva de Castro CC, Fava VM, Sakiyama PH, Dellatorre G, Miot HA (2022) Update on the pathogenesis of vitiligo. An Bras Dermatol 97:478\u201390. https:\/\/doi.org\/10.1016\/j.abd.2021.09.008","journal-title":"An Bras Dermatol"},{"key":"3777_CR5","doi-asserted-by":"publisher","first-page":"4910","DOI":"10.3390\/ijms24054910","volume":"24","author":"F Diotallevi","year":"2023","unstructured":"Diotallevi F, Gioacchini H, De Simoni E, Marani A, Candelora M, Paolinelli M et al (2023) Vitiligo, from pathogenesis to therapeutic advances: state of the art. Int J Mol Sci. 24:4910\u00a0https:\/\/doi.org\/10.3390\/ijms24054910","journal-title":"Int J Mol Sci."},{"key":"3777_CR6","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1159\/000537810","volume":"240","author":"HJ Ju","year":"2024","unstructured":"Ju HJ, Bae JM (2024) Bridging molecular mechanism and clinical practice in vitiligo treatment: an updated review. Dermatology 240:474\u2013486. https:\/\/doi.org\/10.1159\/000537810","journal-title":"Dermatology"},{"key":"3777_CR7","doi-asserted-by":"publisher","first-page":"1112811","DOI":"10.3389\/fimmu.2023.1112811","volume":"14","author":"R Speeckaert","year":"2023","unstructured":"Speeckaert R, Belpaire A, Speeckaert MM, van Geel N (2023) A meta-analysis of chemokines in vitiligo: Recruiting immune cells towards melanocytes. Front Immunol 14:1112811. https:\/\/doi.org\/10.3389\/fimmu.2023.1112811","journal-title":"Front Immunol"},{"key":"3777_CR8","doi-asserted-by":"publisher","first-page":"485","DOI":"10.2340\/00015555-2306","volume":"96","author":"GC de Carvalho","year":"2016","unstructured":"de Carvalho GC, Domingues R, de Sousa Nogueira MA, Calvielli Castelo Branco AC, Gomes Manfrere KC, Pereira NV et al (2016) Up-regulation of proinflammatory genes and cytokines induced by S100A8 in CD8+ T cells in lichen planus. Acta Derm Venereol 96:485\u20139. https:\/\/doi.org\/10.2340\/00015555-2306","journal-title":"Acta Derm Venereol"},{"key":"3777_CR9","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.jaci.2016.10.013","volume":"140","author":"S Li","year":"2017","unstructured":"Li S, Zhu G, Yang Y et al (2017) Oxidative stress drives CD8(+) T-cell skin trafficking in patients with vitiligo through CXCL16 upregulation by activating the unfolded protein response in keratinocytes. J Allergy Clin Immunol 140:177\u201389.e9. https:\/\/doi.org\/10.1016\/j.jaci.2016.10.013","journal-title":"J Allergy Clin Immunol"},{"key":"3777_CR10","doi-asserted-by":"publisher","first-page":"664","DOI":"10.2340\/00015555-2080","volume":"95","author":"L Yang","year":"2015","unstructured":"Yang L, Wei Y, Sun Y and others (2015) Interferon-gamma inhibits melanogenesis and induces apoptosis in melanocytes: a pivotal role of CD8+ cytotoxic T lymphocytes in vitiligo. Acta Derm Venereol 95:664\u2013670. https:\/\/doi.org\/10.2340\/00015555-2080","journal-title":"Acta Derm Venereol"},{"key":"3777_CR11","doi-asserted-by":"publisher","first-page":"382","DOI":"10.3389\/fimmu.2016.00382","volume":"7","author":"E Volpe","year":"2016","unstructured":"Volpe E, Sambucci M, Battistini L, Borsellino G (2016) Fas-Fas ligand: checkpoint of T cell functions in multiple sclerosis. Front Immunol 7:382. https:\/\/doi.org\/10.3389\/fimmu.2016.00382","journal-title":"Front Immunol"},{"key":"3777_CR12","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/j.jmb.2007.04.065","volume":"370","author":"IP Kornd\u00f6rfer","year":"2007","unstructured":"Kornd\u00f6rfer IP, Brueckner F, Skerra A (2007) The crystal structure of the human (S100A8\/S100A9)2 heterotetramer, calprotectin, illustrates how conformational changes of interacting alpha-helices can determine specific association of two EF-hand proteins. J Mol Biol 370:887\u2013898. https:\/\/doi.org\/10.1016\/j.jmb.2007.04.065","journal-title":"J Mol Biol"},{"key":"3777_CR13","doi-asserted-by":"publisher","first-page":"245","DOI":"10.33549\/physiolres.930448","volume":"53","author":"I Str\u00edz","year":"2004","unstructured":"Str\u00edz I, Trebichavsk\u00fd I (2004) Calprotectin - a pleiotropic molecule in acute and chronic inflammation. Physiol Res 53:245\u2013253","journal-title":"Physiol Res"},{"key":"3777_CR14","doi-asserted-by":"publisher","first-page":"223","DOI":"10.2147\/jir.S250675","volume":"13","author":"M Niemel\u00e4","year":"2020","unstructured":"Niemel\u00e4 M, Niemel\u00e4 O, Bloigu R et al (2020) Serum calprotectin, a marker of neutrophil activation, and other mediators of inflammation in response to various types of extreme physical exertion in healthy volunteers. J Inflamm Res 13:223\u2013231. https:\/\/doi.org\/10.2147\/jir.S250675","journal-title":"J Inflamm Res"},{"key":"3777_CR15","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1136\/gutjnl-2021-324855","volume":"70","author":"A Jukic","year":"2021","unstructured":"Jukic A, Bakiri L, Wagner EF et al (2021) Calprotectin: from biomarker to biological function. Gut 70:1978\u20131988. https:\/\/doi.org\/10.1136\/gutjnl-2021-324855","journal-title":"Gut"},{"key":"3777_CR16","doi-asserted-by":"publisher","first-page":"24","DOI":"10.2174\/156652413804486214","volume":"13","author":"R Donato","year":"2013","unstructured":"Donato R, Cannon BR, Sorci G and others (2013) Functions of S100 proteins. Curr Mol Med 13:24\u201357","journal-title":"Curr Mol Med"},{"key":"3777_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0045478","volume":"7","author":"A Cesaro","year":"2012","unstructured":"Cesaro A, Anceriz N, Plante A et al (2012) An inflammation loop orchestrated by S100A9 and calprotectin is critical for development of arthritis. PLoS ONE 7:e45478. https:\/\/doi.org\/10.1371\/journal.pone.0045478","journal-title":"PLoS ONE"},{"key":"3777_CR18","doi-asserted-by":"publisher","first-page":"81","DOI":"10.5826\/dpc.0404a18","volume":"4","author":"A Feily","year":"2014","unstructured":"Feily A (2014) Vitiligo Extent Tensity Index (VETI) score: a new definition, assessment and treatment evaluation criteria in vitiligo. Dermatol Pract Concept 4:81\u201384. https:\/\/doi.org\/10.5826\/dpc.0404a18","journal-title":"Dermatol Pract Concept"},{"key":"3777_CR19","doi-asserted-by":"publisher","first-page":"47","DOI":"10.21608\/bjas.2022.274275","volume":"7","author":"A Ali","year":"2022","unstructured":"Ali A, El-refaei AM, Ahmed AH (2022) Relation between serum and fecal calprotectin and atopic dermatitis. Benha J Appl Sci 7:47\u20135310.1016\/j.abd.2021.09.008","journal-title":"Benha J Appl Sci"},{"key":"3777_CR20","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.ejr.2021.03.002","volume":"43","author":"SA Elwan","year":"2021","unstructured":"Elwan SA, El-Saadany HM, El-Banna HS et al (2021) Serum calprotectin as a potential biomarker for subclinical enthesitis in psoriatic patients. The Egyptian Rheumatologist 43:241\u2013245. https:\/\/doi.org\/10.1016\/j.ejr.2021.03.002","journal-title":"The Egyptian Rheumatologist"},{"key":"3777_CR21","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1111\/jocd.13574","volume":"20","author":"I Fouda","year":"2021","unstructured":"Fouda I, Obaid ZM, Hegazy SF, Samir Abd Al-Samie H, Nofal A (2021) Calprotectin in acne vulgaris: a possible contributory role. J Cosmet Dermatol. 20:621\u2013625","journal-title":"J Cosmet Dermatol."},{"key":"3777_CR22","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1007\/s10495-021-01663-3","volume":"26","author":"A Murao","year":"2021","unstructured":"Murao A, Aziz M, Wang H et al (2021) Release mechanisms of major DAMPs. Apoptosis 26:152\u2013162. https:\/\/doi.org\/10.1007\/s10495-021-01663-3","journal-title":"Apoptosis"},{"key":"3777_CR23","doi-asserted-by":"publisher","first-page":"1069196","DOI":"10.3389\/fimmu.2022.1069196","volume":"13","author":"K He","year":"2022","unstructured":"He K, Wu W, Wang X and others (2022) Circulatory levels of alarmins in patients with non-segmental vitiligo: potential biomarkers for disease diagnosis and activity\/severity assessment. Front Immunol 13:1069196. https:\/\/doi.org\/10.3389\/fimmu.2022.1069196","journal-title":"Front Immunol"},{"key":"3777_CR24","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1172\/jci89867","volume":"128","author":"T Vogl","year":"2018","unstructured":"Vogl T, Stratis A, Wixler V and others (2018) Autoinhibitory regulation of S100A8\/S100A9 alarmin activity locally restricts sterile inflammation. J Clin Invest 128:1852\u20131866. https:\/\/doi.org\/10.1172\/jci89867","journal-title":"J Clin Invest"},{"key":"3777_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2022.103142","volume":"21","author":"MG Danieli","year":"2022","unstructured":"Danieli MG, Antonelli E, Piga MA and others (2022) Alarmins in autoimmune diseases. Autoimmun Rev 21:103142. https:\/\/doi.org\/10.1016\/j.autrev.2022.103142","journal-title":"Autoimmun Rev"},{"key":"3777_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtauto.2021.100111","volume":"4","author":"F Stascheit","year":"2021","unstructured":"Stascheit F, Hotter B, Hoffmann S and others (2021) Calprotectin as potential novel biomarker in myasthenia gravis. J Transl Autoimmun 4:100111. https:\/\/doi.org\/10.1016\/j.jtauto.2021.100111","journal-title":"J Transl Autoimmun"},{"key":"3777_CR27","doi-asserted-by":"publisher","first-page":"112","DOI":"10.4103\/JEWD.JEWD_12_19","volume":"16","author":"AM Hamza","year":"2019","unstructured":"Hamza AM, Hassan EM, Donia HM, Maamon YM (2019) Serum calprotectin as a predictive biomarker in the treatment of psoriasis vulgaris with methotrexate. J Egypt Women\u2019s Dermatol Soc 16:112","journal-title":"J Egypt Women\u2019s Dermatol Soc"},{"key":"3777_CR28","doi-asserted-by":"publisher","first-page":"397","DOI":"10.5114\/ada.2017.71286","volume":"35","author":"S Korkmaz","year":"2018","unstructured":"Korkmaz S, F\u0131\u00e7\u0131c\u0131o\u011flu SK (2018) Calprotectin can play an inflammatory role in acne vulgaris. Postepy Dermatol Alergol 35:397\u2013399. https:\/\/doi.org\/10.5114\/ada.2017.71286","journal-title":"Postepy Dermatol Alergol"}],"container-title":["Irish Journal of Medical Science (1971 -)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-024-03777-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11845-024-03777-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-024-03777-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T12:25:45Z","timestamp":1734956745000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11845-024-03777-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,26]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["3777"],"URL":"https:\/\/doi.org\/10.1007\/s11845-024-03777-4","relation":{},"ISSN":["0021-1265","1863-4362"],"issn-type":[{"value":"0021-1265","type":"print"},{"value":"1863-4362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,26]]},"assertion":[{"value":"13 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board of the Faculty of Medicine (for girls), Al-Azhar University, Cairo, Egypt.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Written informed consents were taken from all participants prior to their enrolment in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Written informed consents were taken from all participants prior to their enrolment in the study for publishing data and any associated photographs.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}